CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 39  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0760
LYS 10.0637
GLU 20.0414
LEU 30.0058
ARG 40.0180
CYS 50.0251
GLN 60.0217
CYS 70.0109
ILE 80.0198
LYS 90.0234
THR 100.0203
TYR 110.0181
SER 120.0174
LYS 130.0117
PRO 140.0165
PHE 150.0242
HIS 160.0296
PRO 170.0090
LYS 180.0113
PHE 190.0082
ILE 200.0044
LYS 210.0087
GLU 220.0074
LEU 230.0026
ARG 240.0101
VAL 250.0104
ILE 260.0098
GLU 270.0129
SER 280.0146
GLY 290.0219
PRO 300.0280
HIS 310.0184
CYS 320.0322
ALA 330.0448
ASN 340.0157
THR 350.0075
GLU 360.0025
ILE 370.0079
ILE 380.0046
VAL 390.0056
LYS 400.0069
LEU 410.0086
SER 420.0109
ASP 430.0262
GLY 440.0157
ARG 450.0134
GLU 460.0089
LEU 470.0114
CYS 480.0104
LEU 490.0136
ASP 500.0185
PRO 510.0140
LYS 520.0159
GLU 530.0142
ASN 540.0206
TRP 550.0106
VAL 560.0089
GLN 570.0164
ARG 580.0163
VAL 590.0144
VAL 600.0132
GLU 610.0275
LYS 620.0120
PHE 630.0032
LEU 640.0144
LYS 650.0083
ARG 660.0236
ALA 670.0221
GLU 680.0305
ASN 690.0760

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.